Cargando…
Pharmacological inactivation of CDK2 inhibits MYC/BCL-XL-driven leukemia in vivo through induction of cellular senescence
Deregulated expression of the MYC oncogene is a frequent event during tumorigenesis and generally correlates with aggressive disease and poor prognosis. While MYC is a potent inducer of apoptosis, it often suppresses cellular senescence, which together with apoptosis is an important barrier against...
Autores principales: | Bazzar, Wesam, Bocci, Matteo, Hejll, Eduar, Högqvist Tabor, Vedrana, Hydbring, Per, Grandien, Alf, Alzrigat, Mohammad, Larsson, Lars-Gunnar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849765/ https://www.ncbi.nlm.nih.gov/pubmed/33356836 http://dx.doi.org/10.1080/15384101.2020.1855740 |
Ejemplares similares
-
Inhibition of the Intrinsic but Not the Extrinsic Apoptosis Pathway Accelerates and Drives Myc-Driven Tumorigenesis Towards Acute Myeloid Leukemia
por: Högstrand, Kari, et al.
Publicado: (2012) -
Cdk2: a key regulator of the senescence control function of Myc
por: Hydbring, Per, et al.
Publicado: (2010) -
MYC and RAS are unable to cooperate in overcoming cellular senescence and apoptosis in normal human fibroblasts
por: Zhang, Fan, et al.
Publicado: (2018) -
MYC Modulation around the CDK2/p27/SKP2 Axis
por: Hydbring, Per, et al.
Publicado: (2017) -
A selective high affinity MYC-binding compound inhibits MYC:MAX interaction and MYC-dependent tumor cell proliferation
por: Castell, Alina, et al.
Publicado: (2018)